D. E. Shaw & Co., Inc. Tandem Diabetes Care Inc Call Options Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $356,574 - $824,703	6,700 Added 67.0%	16,700 $988,000
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $864,000 - $1.22 Million	-10,000 Reduced 50.0%	10,000 $957,000
Q3 2020 Nov 16, 2020	SELL	$95.43 - $116.09 $1.91 Million - $2.32 Million	-20,000 Reduced 50.0%	20,000 $2.27 Million
Q4 2019 Feb 14, 2020	SELL	$53.13 - $71.19 $47,817 - $64,071	-900 Reduced 2.2%	40,000 $2.38 Million
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $845,228 - $1.08 Million	-14,800 Reduced 26.57%	40,900 $2.41 Million

Q2 2019 Aug 14, 2019	SELL	$54.41 - $71.7 $1.21 Million - $1.6 Million	-22,300 Reduced 28.59%	55,700 $3.59 Million
Q1 2019 May 15, 2019	BUY	$32.25 - $73.56 $1.9 Million - $4.33 Million	58,900 Added 308.38%	78,000 $4.95 Million
Q4 2018 Feb 14, 2019	BUY	$28.45 - $40.65 $543,395 - $776,415	19,100 New	19,100 $725,000

312

73.1M

3.25M

250K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.6B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.